Issue link: https://www.e-digitaleditions.com/i/1521797
This section provides information that may be useful in research and development or manufacturing. Content is provided by the companies listed. No endorsement or preference is intended. 20 June 2024 Inhalation ISSUE FOCUS Nasal Delivery, Nebulizers and Soft Mist Inhalers This section of Inhalation provides information that may be useful in research and development or manufacturing. Content is provided by the companies listed. No product endorsement or preference is intended. Nasal drug product testing with cascade impaction Ensuring the safety and efficacy of nasal medications depends on careful testing methods. At the heart of this process are cascade impactor testing devices with glass expansion chambers. ese chambers facilitate atomization and dispersion of the dose, also allowing for sampling in the impactor. With variable volumes of 1 liter, 2 liter and 5 liter, these chambers aim to optimize testing for worst-case scenarios and maxi- mize aerosolization to fully assess the risks of pulmo- nary deposition. Such standardized approaches are essential to ensure the quality and reliability of nasal drug testing protocols. MSP™, a Division of TSI ® US: +1 651 287-8100 mspsales@tsi.com www.tsi.com Nasal drug products require precise testing Traditional manual testing methods are time- consuming and prone to errors, leading to increased risk of out-of-spec results. Proveris Scientific's Vereo NSx+ SWC (spray, weigh and collect) benchtop nasal spray testing system utilizes trusted Viota ® software and provides automated actuation, sample collec- tion and weighing, reducing time and errors associ- ated with through-life testing. Enable "Seconds to Weight" with the Vereo NSx+ SWC. Proveris Scientific Corporation US: +1 508 460-8822 www.proveris.com